-
01:24
1.
index 1
-
10:40
2.
HBx-downregulated circSFMBT2 in HCC cell lines
-
03:55
3.
HBx-downregulated circSFMBT2 in HCC cell lines
-
00:51
4.
Level of CircSFMBT2 in HBV(+) or HBV(-) tumorous tissues and paired adjacent nontumorous tissues
-
06:59
5.
CircSFMBT2 is expressed at low levels in HCC and correlates with poor prognosis and invasion
-
04:49
6.
CircSFMBT2 is expressed at low levels in HCC and correlates with poor prognosis and invasion
-
00:06
7.
CircSFMBT2 inhibits HCC metastasis in vitro
-
05:29
8.
CircSFMBT2 is expressed at low levels in HCC and correlates with poor prognosis and invasion
-
01:28
9.
CircSFMBT2 inhibits HCC metastasis in vitro
-
00:00
10.
CircSFMBT2 is expressed at low levels in HCC and correlates with poor prognosis and invasion
-
00:01
11.
CircSFMBT2 is expressed at low levels in HCC and correlates with poor prognosis and invasion
-
00:00
12.
Level of CircSFMBT2 in HBV(+) or HBV(-) tumorous tissues and paired adjacent nontumorous tissues
-
00:03
13.
HBx-downregulated circSFMBT2 in HCC cell lines
-
00:41
14.
HBx-downregulated circSFMBT2 in HCC cell lines
-
00:00
15.
HBx-downregulated circSFMBT2 in HCC cell lines
-
00:00
16.
Level of CircSFMBT2 in HBV(+) or HBV(-) tumorous tissues and paired adjacent nontumorous tissues
-
00:05
17.
CircSFMBT2 is expressed at low levels in HCC and correlates with poor prognosis and invasion
-
00:00
18.
CircSFMBT2 is expressed at low levels in HCC and correlates with poor prognosis and invasion
-
06:19
19.
CircSFMBT2 inhibits HCC metastasis in vitro
-
02:58
20.
CircSFMBT2 inhibits HCC metastasis in vitro
-
00:04
21.
CircSFMBT2 inhibits HCC metastasis in vitro
-
00:00
22.
CircSFMBT2 is expressed at low levels in HCC and correlates with poor prognosis and invasion
-
01:00
23.
CircSFMBT2 is expressed at low levels in HCC and correlates with poor prognosis and invasion
-
00:00
24.
CircSFMBT2 is expressed at low levels in HCC and correlates with poor prognosis and invasion
-
00:01
25.
CircSFMBT2 inhibits HCC metastasis in vitro
-
00:02
26.
CircSFMBT2 inhibits HCC metastasis in vitro
-
03:33
27.
CircSFMBT2 inhibits HCC metastasis in vivo
-
11:26
28.
CircSFMBT2 acts as a sponge of miR-665
-
00:04
29.
CircSFMBT2 acts as a sponge of miR-665
-
02:12
30.
CircSFMBT2 acts as a sponge of miR-665
-
03:35
31.
CircSFMBT2 acts as a sponge of miR-665
-
00:06
32.
CircSFMBT2 acts as a sponge of miR-665
-
00:48
33.
CircSFMBT2 acts as a sponge of miR-665
-
00:51
34.
CircSFMBT2 acts as a sponge of miR-665
-
01:55
35.
CircSFMBT2 regulates HCC metastasis through the miR-665/TIMP3 axis
-
04:35
36.
CircSFMBT2 regulates HCC metastasis through the miR-665/TIMP3 axis
-
01:03
37.
CircSFMBT2 regulates HCC metastasis through the miR-665/TIMP3 axis
-
00:06
38.
HBx facilitates HCC metastasis through circSFMBT2/miR-665/TIMP3 pathways
-
00:09
39.
HBx facilitates HCC metastasis through circSFMBT2/miR-665/TIMP3 pathways
-
00:03
40.
HBx facilitates HCC metastasis through circSFMBT2/miR-665/TIMP3 pathways
-
03:16
41.
HBx downregulates circSFMBT2 via interacting with DHX9 and promoting DHX9 to bind flanking Alu elements
-
00:08
42.
HBx downregulates circSFMBT2 via interacting with DHX9 and promoting DHX9 to bind flanking Alu elements
-
00:53
43.
HBx downregulates circSFMBT2 via interacting with DHX9 and promoting DHX9 to bind flanking Alu elements
-
00:41
44.
HBx downregulates circSFMBT2 via interacting with DHX9 and promoting DHX9 to bind flanking Alu elements
-
01:12
45.
HBx downregulates circSFMBT2 via interacting with DHX9 and promoting DHX9 to bind flanking Alu elements
-
01:44
46.
Slide 24